Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On February 4, 2026, enVVeno Medical Corporation (the “Company”) announced that as of December 31, 2025, the Comp
. Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit Number Exhibit Description 99.1 Press Release, dated February 4, 2026 104 Cover Page Interact